Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Haleon plc
Haleon plc News
Haleon plc Quantitative Score
About Haleon plc
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Haleon plc Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Haleon plc Financials
Table Compare
Compare HLN metrics with: | |||
|---|---|---|---|
Earnings & Growth | HLN | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | HLN | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | HLN | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | HLN | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Haleon plc Income
Haleon plc Balance Sheet
Haleon plc Cash Flow
Haleon plc Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Buy |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Haleon plc Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.3342 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-09-18 | 0.059783 | Quarterly |
| 2025-06-05 | 0.11661 | Quarterly |
| 2024-09-19 | 0.051416 | Quarterly |
| 2024-05-16 | 0.10635 | Quarterly |
| 2023-10-05 | 0.0459936 | Quarterly |
Historical Market Cap
Shares Outstanding
Haleon plc Executives
| Name | Role |
|---|---|
| Mr. Brian James McNamara | Chief Executive Officer & Executive Director |
| Ms. Dawn Amanda Allen | Chief Financial Officer & Director |
| Ms. Joanne Russell | Head of Investor Relations |
| Mr. Adrian Charles Morris | General Counsel |
| Ms. Lisa Paley | President of North America |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Brian James McNamara | Chief Executive Officer & Executive Director | Male | 1966 | 3.96M |
| Ms. Dawn Amanda Allen | Chief Financial Officer & Director | Female | 1968 | 1.27M |
| Ms. Joanne Russell | Head of Investor Relations | Female | -- | |
| Mr. Adrian Charles Morris | General Counsel | Male | 1967 | -- |
| Ms. Lisa Paley | President of North America | Female | 1967 | -- |